Announcement on Receiving the Shenzhen Stock Exchange's Decision to Terminate the Review of Shenyang Xingqi Eye Medicine Co., Ltd.'s Application for Stock Issuance

Shenyang Xingqi Eye Medicine Co., Ltd. (hereinafter referred to as "the Company") held the 17th meeting of the 5th Board of Directors and the 2026 second meeting of the independent directors on May 25, 2026, where it reviewed and approved the proposal to terminate the issuance of A-shares to specific targets and to withdraw the application documents. The Company agreed to terminate this stock issuance matter and applied to the Shenzhen Stock Exchange (hereinafter referred to as "SZSE") to withdraw the relevant application documents. For specific details, please refer to the announcement titled "Announcement on Terminat